0.0958SEK+2.13%Mkt Cap: 129.31M SEKP/E: —Last update: 2026-06-01
Simris Group AB (PUBL), a biotechnology company, develops antibody-drug conjugate (ADC) payloads in Sweden and internationally. The company develops, manufactures, and sells bioactive substances from cultured microalgae …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap129.31M SEK
Enterprise Value68.23M SEK
Revenue (TTM)2.65M SEK
Gross Profit1.76M SEK
Net Income (TTM)-26.81M SEK
Revenue/Share0.0030 SEK
Last Price0.0958 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees5
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-4.90
EV/Revenue25.79
P/S47.85
P/B-93.80
EPS (TTM)-0.03
EPS (Forward)—
52W Range
0.040225% of range0.2610
52W High0.2610 SEK
52W Low0.0402 SEK
Profitability
Gross Margin109.29%
Oper. Margin-472.77%
EBITDA Margin0.00%
Profit Margin-1660.12%
ROE5704.47%
ROA-18.07%
Growth
Revenue Growth648.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-16.05M SEK
CapEx (TTM)224.00K SEK
FCF Margin-510.81%
FCF Yield-10.45%
Net Debt-10.76M SEK
Net Debt/EBITDA0.77
Balance Sheet
Debt/Equity-5.44
Current Ratio0.99
Quick Ratio0.90
Book Value/Sh-0.0010 SEK
Cash/Share0.0130 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.35B
Float760.49M
Insiders7.24%
Institutions0.44%
Technical
SMA 500.0909 (+5.4%)
SMA 2000.0974 (-1.6%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)244.74K
Avg Vol (10d)388.45K
Technical Indicators
RSI (14)51.1
MACD-0.0005
MACD Signal0.0002
MACD Hist.-0.0007
BB Upper0.1104 SEK
BB Middle0.0942 SEK
BB Lower0.0781 SEK
BB Width34.28%
ATR (14)0.0126 SEK
Vol Ratio (20d)0.34x